Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00231218 · ClinicalTrials.gov registry record · Phase 3

Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers

A Phase 3 study, sponsored by The Cleveland Clinic.

Completed
Registry status
Phase 3
Development phase
104
Enrollment target

NCT00231218 is a Phase 3 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 104 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00231218, a Phase 3 study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
Phase 3
Development phase
104 participants
Enrollment target

Study Summary

We hypothesize the herbal preparation will enhance the preschoolers' immune response and when taken prophylactically for 12 weeks will decrease episodes of upper respiratory infections and gastroenteritis in the active versus the control group.

Interventions

  • DRUG dietary supplement--echinacea, propolis, and vitamin c

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2006-01
Est. Completion 2006-03
Phase Phase 3

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT00231218

The ClinicalTrials.gov registry entry for NCT00231218 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which dietary supplement--echinacea, propolis, and vitamin c is the first listed.

NCT00231218 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00231218 about?

NCT00231218 is a clinical study titled "Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers". We hypothesize the herbal preparation will enhance the preschoolers' immune response and when taken prophylactically for 12 weeks will decrease episodes of upper respiratory infections and gastroenteritis in the active versus the control group.

What is the current status of trial NCT00231218?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 104 participants. The study started on 2006-01. Estimated completion is 2006-03.

What interventions are being tested in trial NCT00231218?

The interventions under investigation include: dietary supplement--echinacea, propolis, and vitamin c (DRUG).

Who is sponsoring clinical trial NCT00231218?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.